Posted by Anonymous on 2008-02-23
Tags: Funding Sources
How are early stage biopharma companies getting funded these days" We have good pre-clinical data and are working to raise funds for a Phase I clinical trial. We've talked to several of the larger coastal funds who (for the most part) have been polite but consistently call us too early, which is consistent with their investment history in the sector. We need to raise between $5-7 million and are not on one of the coasts. This seems like an awkward space. I've had the opportunity to present to several of the top-tier VCs. Most of whom have been interested, engaged and polite BUT the truth is that their track record indicates they are not doing these deals. Their biopharma deals tend to be later stage and greater than $15 million. I understand deal flow but it seems like a waste of everyones time and gets back to the question "who funds early stage biopharma" Advise is greatly appreciated.